News - Clinical pharmacology
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 





DateSubject
06/20/2008 02:42:24 PM
Rolofylline Reduces Congestion and Improves Renal Function for Patients Hospitalised With Acute Heart Failure and Volume Overload: Presented at HF2008
06/20/2008 08:56:04 AM
Bosentan Reduces Clinical Decline of Patients With Early-Stage Pulmonary Arterial Hypertension
06/20/2008 08:52:43 AM
Aciclovir Does Not Reduce HIV Acquisition in Women or Gay Men With Genital Herpes
06/20/2008 08:49:57 AM
New Oral Drug Laquinimod Appears to Reduce Disease Activity in Patients With Relapse-Remitting MS
06/19/2008 04:21:08 PM
Incident Dementia Reduced by Antihypertensive Therapy in Elderly Hypertensive Patients: Presented at ESH
06/19/2008 04:17:28 PM
Morbidity and Mortality Benefits of Antihypertensive Therapy Shown for All Major Subgroups in Elderly: Presented at ESH
06/19/2008 04:14:17 PM
Kidney Transplant Patients Benefit From Calcineurin Inhibitor Withdrawal Regimen
06/19/2008 04:11:55 PM
Metformin Improves Insulin Sensitivity, Promotes Weight Loss, and Provides Improved Cholesterol Control for Obese Children With Insulin Resistance: Presented at ENDO 08
06/19/2008 04:08:22 PM
Aliskiren Produces Sustained Blood Pressure Reduction Even After Missed Dose: Presented at ESH
06/19/2008 04:05:13 PM
Nonadherence to Antiepileptic Drugs Associated With Increased Mortality
06/19/2008 09:22:55 AM
Hypertension Treatment Effective in Reversing Vascular Damage
06/19/2008 09:19:59 AM
Allopurinol Improves Diastolic Function and Lowers NT-proBNP Levels in Heart Failure Patients: Presented at HF2008
06/19/2008 09:15:50 AM
Ivabradine Improves Heart Rate and Left-Ventricular Function in Patients With Severe Systolic Chronic Heart Failure on Beta-Blockers: Presented at HF2008
06/18/2008 05:46:52 PM
Gene Variation Explains Ineffectiveness of Cholesterol-Lowering Drugs in Some Patients
06/18/2008 05:46:39 PM
Piboserod Improves Left-Ventricular Function in Patients With Symptomatic Heart Failure: Presented at HF2008
06/18/2008 03:59:29 PM
Bisoprolol and Enalapril Monotherapies Have Similar Efficacies in Mild to Moderate Chronic Heart Failure: Presented at HF2008
06/18/2008 03:57:01 PM
Rosuvastatin Increases Endothelial Progenitor Cells in Patients With Heart Failure: Presented at HF2008
06/18/2008 03:53:45 PM
Hypertension Remains a Predictor of Cardiovascular Risk Even After Lipid-Lowering Therapy: Presented at ESH
06/18/2008 03:51:37 PM
Gene Mutation Improves Leukaemia Drug's Effect
06/18/2008 03:48:40 PM
Amlodipine Reduces Left Ventricular Hypertrophy Better Than Atenolol: Presented at ESH
06/18/2008 03:45:40 PM
Anticoagulants Comparable for Venous Thromboembolism Prevention in Myeloma Patients Receiving Thalidomide Regimens: Presented at EHA
06/18/2008 03:24:28 PM
FDA Requests Boxed Warnings on Conventional Antipsychotic Drugs
06/17/2008 05:35:52 PM
Interferon-Beta May Have Disease Modifying Effect in Patients With B19-Positive Inflammatory Cardiomyopathy: Presented at HF2008
06/17/2008 05:24:55 PM
Dasatinib Benefits Children and Adolescents With Relapsed or Refractory Leukaemia: Presented at EHA
06/17/2008 05:23:10 PM
TGA Approves Panvax, Avian Flu Vaccine
06/17/2008 05:19:27 PM
Frontline Dasatinib Demonstrates Rapid Response in Patients With Previously Untreated Chronic-Phase Chronic Myeloid Leukaemia: Presented at EHA
06/17/2008 05:17:20 PM
High-Dose Imatinib Offers No Additional Benefit to Standard Dose as First-Line Therapy for High-Risk Chronic-Phase Chronic Myeloid Leukaemia: Presented at EHA
06/17/2008 05:14:41 PM
Dasatinib Monotherapy Effective and Feasible as First-Line Treatment of Adult Philadelphia-Chromosome Positive Acute Lymphoblastic Leukaemia: Presented at EHA
06/17/2008 01:07:56 PM
Etanercept Plus Methotrexate Prevents Joint Damage in Early Active Rheumatoid Arthritis: Presented at EULAR
06/17/2008 01:05:43 PM
Melphalan, Prednisone, and Thalidomide Combo Improves Progression-Free Survival but Not Overall Survival in Older Patients With Multiple Myeloma: Presented at EHA
06/17/2008 12:42:40 PM
Eculizumab Improves Fatigue Independent of Changes in Anaemia in Patients With Paroxysmal Nocturnal Haemoglobinuria: Presented at EHA
06/17/2008 10:42:32 AM
Cinaciguat Safely Improves Cardiopulmonary Haemodynamics in Acute Decompensated Heart Failure: Presented at HF2008
06/17/2008 10:30:56 AM
FDA Approves Triamcinolone Acetone Formulation for Ocular Use
06/16/2008 10:29:27 PM
No Link Between Ibandronate and Atrial Fibrillation in Postmenopausal Osteoporosis Patients: Presented at EULAR
06/16/2008 10:25:35 PM
Oral Anticoagulant Dabigatran Etexilate Approved in Canada
06/16/2008 10:23:00 PM
Abatacept and Infliximab Improve ACR and LDAS in Methotrexate-Refractory RA Patients
06/16/2008 10:20:37 PM
Chinese Study: Carbocisteine Prevents COPD Exacerbations
06/16/2008 10:11:39 PM
Levosimendan Infusion Provides Prolonged Efficacy and Safety in Patients With Acute Heart Failure: Presented at HF2008
06/16/2008 05:44:21 PM
Tocilizumab Tops Methotrexate Monotherapy in Rheumatoid Arthritis Patient-Reported Outcomes: Presented at EULAR
06/16/2008 11:53:57 AM
Bortezomib Added to Melphalan-Prednisone Significantly Improves Overall Survival in Previously Untreated Patients With Multiple Myeloma: Presented at EHA
06/16/2008 11:50:54 AM
Duloxetine Safety in Fibromyalgia Sustained Up to 60 Weeks and Comparable to Other Uses of the Drug: Presented at EULAR
06/16/2008 11:47:03 AM
Belimumab Effective in Patients With Serologically Active Systemic Lupus Erythematosus: Presented at EULAR
06/16/2008 10:43:11 AM
FDA Approves Duloxetine HCl for the Management of Fibromyalgia
06/16/2008 08:55:08 AM
Metformin Slows Early-Onset Puberty in Girls
06/15/2008 06:35:22 PM
High-Dose Imatinib Followed by Maintenance Not Significantly Different Than Continuous Standard-Dose Imatinib in Patients With Previously Treated Chronic Phase Chronic Myeloid Leukaemia: Presented at EHA
06/15/2008 05:47:10 PM
Tolvaptan Combo Therapy Provides Significant Advantage Over Therapy Alone in Treating Acute Heart Failure Syndromes: Presented at HF2008
06/15/2008 05:36:18 PM
Intravenous Quercetin Significantly Reduces Mortality in STEMI: Presented at HF2008
06/15/2008 05:28:55 PM
Tocilizumab Monotherapy Tops Methotrexate Monotherapy for Patients With Rheumatoid Arthritis: Presented at EULAR
06/15/2008 05:26:35 PM
Certolizumab Pegol Provides Important Benefits in Patients With Rheumatoid Arthritis: Presented at EULAR
06/15/2008 05:23:54 PM
Rituximab Retreatment Preflare Advised in Patients Responding to Rituximab After TNF Failure: Presented at EULAR
06/15/2008 05:13:55 PM
High-Dose Imatinib Offers No Benefit as First- Line Therapy for High-Risk Chronic-Phase CML: Presented at EHA
06/15/2008 05:11:47 PM
Interim Analysis: First-Line Nilotinib Effective in Patients With Chronic Myeloid Leukaemia: Presented at EHA
06/15/2008 12:53:08 PM
Bosutinib Induces Response in Patients With CML Resistant or Intolerant to Imatinib, Other TKIs: Presented at EHA
06/15/2008 12:23:09 PM
Consolidation With Radiolabeled MAb Delays Progression of Advanced Follicular Lymphoma: Presented at EHA
06/15/2008 12:19:09 PM
Tocilizumab Boosts Outcomes in Patients With Rheumatoid Arthritis Refractory to TNF-Antagonists: Presented at EULAR
06/15/2008 12:13:31 PM
Zoledronic Acid Better for Bone Remodelling Than Risedronate in Glucocorticoid-Induced Osteoporosis: Presented at EULAR
06/15/2008 09:54:56 AM
Adalimumab Demonstrates Long-Term Benefit in Ankylosing Spondylitis: Presented at EULAR
06/15/2008 09:24:15 AM
Infliximab Monotherapy Effective for Long-Term Treatment of Spondyloarthritis: Presented at EULAR
06/15/2008 08:57:57 AM
Dasatinib Benefits Patients With Chronic-Phase CML Failing Imatinib: Presented at EHA
06/15/2008 08:55:12 AM
High-Dose vs Standard-Dose Imatinib in Treatment-Naive Patients With Newly Diagnosed CML: Presented at EHA
06/15/2008 08:53:22 AM
Golimumab Effective in Patients With Rheumatoid Arthritis Not Responding to Methotrexate: Presented at EULAR
06/15/2008 08:50:03 AM
FDG-PET Useful in Tailoring Therapy for Patients With Advanced Hodgkin's Lymphoma: Presented at EHA
06/15/2008 08:43:45 AM
Intensive Induction Therapy Followed by Stem-Cell Support and Consolidation Therapy Produces High Responses in Elderly With Multiple Myeloma: Presented at EHA
06/15/2008 08:40:05 AM
Adalimumab Cuts Uveitis Flares: Presented at EULAR
06/15/2008 08:29:02 AM
Data Support Azacytidine as First-Line Therapy for Patients With High-Risk MDS: Presented at EHA
06/14/2008 04:20:28 PM
Adding Infliximab to Combination DMARD Treatment for Early Rheumatoid Arthritis Increases Remission Rate, Prevention of Radiological Progression: Presented at EULAR
06/14/2008 02:08:14 PM
Malignancies in Etanercept-Treated Patients Uncommon: Presented at EULAR
06/13/2008 05:45:14 PM
Rheumatoid Arthritis Patients Refractory to Anti-TNFs Achieve Disease Remission With Tocilizumab Plus Methotrexate
06/13/2008 04:40:18 PM
Teriparatide Tops Alendronate in Multiple Subgroups at Increased Fracture Risk: Presented at EULAR
06/13/2008 04:30:39 PM
Adalimumab Effective in Patients With Rheumatic Disease Unresponsive to Other Anti-TNF Therapies
06/13/2008 03:26:42 PM
Memantine Provides Significant Effects on 3 Key Cognitive Domains in Patients With Alzheimer's Disease: Presented at ENS
06/13/2008 03:12:30 PM
VNP40101M Plus Cytarabine Demonstrates Benefit Over Cytarabine Alone in Relapsed Acute Myelogenous Leukaemia: Presented at EHA
06/13/2008 02:43:27 PM
Eltrombopag Demonstrates Safety and Efficacy in Idiopathic Thrombocytopenic Purpura: Presented at EHA
06/13/2008 02:37:21 PM
Golimumab Effective for RA in Patients Who Discontinue Prior Anti-TNF-Alpha Therapy: Presented at EULAR
06/13/2008 11:34:12 AM
Lapatinib Approved in Europe for Breast Cancer
06/13/2008 08:10:37 AM
Pregabalin Results in Pain Relief in Fibromyalgia Patients: Presented at EULAR
06/13/2008 08:07:29 AM
Pregabalin Effective for Fibromyalgia Pain Regardless of Patient Anxiety or Depression: Presented at EULAR
06/12/2008 04:20:13 PM
Rituximab Maintains Inhibition of Structural Damage at 2 Years in Patients With Rheumatoid Arthritis: Presented at EULAR
06/12/2008 04:16:49 PM
Milnacipran Shows Good Results in Fibromyalgia Patients: Presented at EULAR
06/12/2008 10:53:57 AM
Sublingual Immunotherapy Benefits for Grass-Induced Asthma: Presented at EAACI
06/12/2008 10:14:33 AM
Dexamethasone Improves Outcomes in Bacterial Meningitis When Implemented According to Recommendations: Presented at ENS
06/11/2008 10:11:34 PM
Antihypertensive Treatment Can Significantly Slow Down Cognitive Decline in Alzheimer's Disease: Presented at ENS
06/11/2008 03:23:39 PM
Modified Islet Cell Transplantation Leads to Insulin Independence in Patients With Type 1 Diabetes
06/11/2008 10:27:32 AM
Once-Weekly Exenatide Shows Enduring Control of Diabetes: Presented at ADA
06/11/2008 10:25:15 AM
Pioglitazone Prevents Conversion to Diabetes Among Insulin-Resistant Patients: Presented at ADA
06/10/2008 05:31:27 PM
Mometasone Furoate Nasal Spray Improves Congestion Associated With Seasonal Allergic Rhinitis: Presented at EAACI
06/10/2008 05:28:53 PM
Desloratadine Reduces Patient-Rated Symptoms of Intermittent Allergic Rhinitis: Presented at EAACI
06/10/2008 04:27:45 PM
Short Course Immunotherapy Containing Monophosphoryl Lipid A Adjuvant Shows Good Long-Term Efficacy: Presented at EAACI
06/10/2008 04:10:04 PM
Raloxifene Reduces Risk of Invasive Estrogen Receptor-Positive Breast Cancer
06/10/2008 03:56:23 PM
Adherence to Disease-Modifying Therapy in Multiple Sclerosis Highest in Subcutaneous Interferon Beta-1a and Glatiramer Acetate: Presented at ENS
06/10/2008 03:39:43 PM
Fotemustine Shows Activity as Single Agent in Recurrent or Progressive Gliomas: Presented at ENS
06/10/2008 03:36:57 PM
Patients Rate Rupatadine, Ebastine, and Loratadine Effective in Treating Allergic Rhinitis: Presented at EAACI
06/10/2008 11:59:42 AM
Single Lot of Morphine Sulfate 60-mg Extended Release Tablets Recalled
06/09/2008 05:44:16 PM
Veterans Affairs Trial Fails to Establish Lower Haemoglobin as Protective Against Cardiovascular Events: Presented at ADA
06/09/2008 05:04:40 PM
Diabetes Medication Associated With Slower Progression of Retina Disease
06/09/2008 05:00:23 PM
Sitagliptin Lowers Risk of Hypoglycaemia in Type 2 Diabetes: Presented at ADA
06/09/2008 04:58:41 PM
Combination Sitagliptin and Metformin Shows Substantial Beta-Cell Function Improvement at 2 Years: Presented at ADA
06/09/2008 04:56:53 PM
High-Dose Cyclophosphamide Appears to Reduce Disease Activity, Disability in Patients With MS
06/09/2008 04:51:16 PM
Topiramate Reduces Heavy Drinking and Symptoms of Alcoholism
06/09/2008 02:37:35 PM
Liraglutide Provides Multiple Benefits Over Glimepiride in Type 2 Diabetes: Presented at ADA
06/09/2008 02:34:49 PM

[Next Page]